Brentuximab vedotin plus chemotherapy for stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study Meeting Abstract
| Authors: | Radford, J.; Bartlett, N.; Straus, D.; Dlugosz-Danecka, M.; Alekseev, S.; Illes, A.; Lech-Maranda, E.; Feldman, T.; Smolewski, P.; Savage, K.; Walewski, J.; Ramchandren, R.; Zinzani, P. L.; Hutchings, M.; Connors, J.; Munoz, J.; Kim, W. S.; Advani, R.; Ansell, S.; Younes, A.; Gallamini, A.; Miao, H.; Liu, R.; Fenton, K.; Forero-Torres, A.; Picardi, M. |
| Abstract Title: | Brentuximab vedotin plus chemotherapy for stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study |
| Meeting Title: | 60th Annual Scientific Meeting of the British Society for Haematology (BSH) |
| Journal Title: | British Journal of Haematology |
| Volume: | 189 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Apr 27-29 |
| Meeting Location: | Birmingham, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2020-04-01 |
| Start Page: | 101 |
| End Page: | 102 |
| Language: | English |
| ACCESSION: | WOS:000528597400137 |
| PROVIDER: | wos |
| PUBMED: | 32337705 |
| DOI: | 10.1111/bjh.16638 |
| Notes: | Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-089 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
